Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

633
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
633
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers.

Histopathology·2020
Same author

Authors' response to "malignant mesothelioma following exposure to cosmetic talc: Association, not causation".

American journal of industrial medicine·2020
Same author

Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients.

American journal of industrial medicine·2020
Same author

Multiple calcifying fibrous pseudotumors of the pleura: ultrastructural analysis provides insight on mechanism of dissemination.

Ultrastructural pathology·2019
Same author

Malignant mesothelioma in Lynch syndrome: A report of two cases and a review of the literature.

American journal of industrial medicine·2019
Same author

A Conserved Distal Lung Regenerative Pathway in Acute Lung Injury.

The American journal of pathology·2018

Related Experiment Video

Updated: Mar 31, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K

Honeycomb Lung: Time for a Change.

Richard L Kradin1

  • 1From the Departments of Pathology, Pulmonary and Critical Care Medicine, and Medicine, Massachusetts General Hospital, Boston.

Archives of Pathology & Laboratory Medicine
|October 31, 2015
PubMed
Summary
This summary is machine-generated.

New medications for idiopathic pulmonary fibrosis highlight diagnostic accuracy concerns. A proposed "dying back" acinar model may improve usual interstitial pneumonia diagnosis and understanding of its pathogenesis.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

12.3K

Related Experiment Videos

Last Updated: Mar 31, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

12.3K

Area of Science:

  • Pulmonary Medicine
  • Pathology
  • Radiology

Background:

  • New US Food and Drug Administration-approved medications for idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP) necessitate accurate diagnosis.
  • The current diagnostic term 'honeycomb lung' is a late-stage descriptor lacking biological insight.
  • Accurate diagnosis is critical for effective treatment and patient management.

Purpose of the Study:

  • To propose a novel conceptualization of end-stage lung disease in usual interstitial pneumonia.
  • To enhance the diagnostic accuracy (sensitivity and specificity) of usual interstitial pneumonia.
  • To provide a better understanding of the pathogenesis of usual interstitial pneumonia.

Main Methods:

  • Review of current diagnostic criteria and terminology for usual interstitial pneumonia.
  • Conceptual development based on the "dying back" of the pulmonary acinus.
  • Analysis of pathological and radiological features associated with disease progression.

Main Results:

  • The term "honeycomb lung" is identified as a non-specific, late-stage finding.
  • A new model of end-stage usual interstitial pneumonia based on acinar atrophy is proposed.
  • This conceptual shift may offer improved diagnostic precision.

Conclusions:

  • The proposed "dying back" acinar model offers a more biologically relevant framework for understanding end-stage usual interstitial pneumonia.
  • This new conception has the potential to improve diagnostic accuracy and guide future research into pathogenesis.
  • Rethinking diagnostic terminology is crucial in the era of targeted IPF therapies.